Hodeib M - Search Results

1

Recurrence and risk of progression to lower genital tract malignancy in women with high grade VAIN.

Hodeib M, Cohen JG, Mehta S, Rimel BJ, Walsh CS, Li AJ, Karlan BY, Cass I. Hodeib M, et al. Gynecol Oncol. 2016 Jun;141(3):507-510. doi: 10.1016/j.ygyno.2016.03.033. Epub 2016 Apr 2. Gynecol Oncol. 2016. PMID: 27032375

2

Socioeconomic status as a predictor of adherence to treatment guidelines for early-stage ovarian cancer.

Hodeib M, Chang J, Liu F, Ziogas A, Dilley S, Randall LM, Anton-Culver H, Bristow RE. Hodeib M, et al. Gynecol Oncol. 2015 Jul;138(1):121-7. doi: 10.1016/j.ygyno.2015.04.011. Epub 2015 Apr 22. Gynecol Oncol. 2015. PMID: 25913132 Free PMC article.

3

Leveraging DNA repair deficiency in gynecologic oncology.

Walsh CS, Hodeib M. Walsh CS, et al. Among authors: hodeib m. Curr Opin Obstet Gynecol. 2016 Feb;28(1):24-31. doi: 10.1097/GCO.0000000000000236. Curr Opin Obstet Gynecol. 2016. PMID: 26694829 Review.

4

Metformin induces distinct bioenergetic and metabolic profiles in sensitive versus resistant high grade serous ovarian cancer and normal fallopian tube secretory epithelial cells.

Hodeib M, Ogrodzinski MP, Vergnes L, Reue K, Karlan BY, Lunt SY, Aspuria PP. Hodeib M, et al. Oncotarget. 2017 Dec 23;9(3):4044-4060. doi: 10.18632/oncotarget.23661. eCollection 2018 Jan 9. Oncotarget. 2017. PMID: 29423103 Free PMC article.

5

Sebaceous carcinoma arising within an ovarian mature cystic teratoma: A case report with discussion of clinical management and genetic evaluation.

Wield A, Hodeib M, Khan M, Gubernick L, Li AJ, Kandukuri S. Wield A, et al. Among authors: hodeib m. Gynecol Oncol Rep. 2018 Aug 29;26:37-40. doi: 10.1016/j.gore.2018.08.011. eCollection 2018 Nov. Gynecol Oncol Rep. 2018. PMID: 30225334 Free PMC article.

6

Clinical use of PARP inhibitor in recurrent uterine leiomyosarcoma with presence of a somatic BRCA2 mutation.

Shammas N, Yang T, Abidi A, Amneus M, Hodeib M. Shammas N, et al. Among authors: hodeib m. Gynecol Oncol Rep. 2022 Jul 14;42:101044. doi: 10.1016/j.gore.2022.101044. eCollection 2022 Aug. Gynecol Oncol Rep. 2022. PMID: 35866178 Free PMC article.

7

Survival impact of complete cytoreduction to no gross residual disease for advanced-stage ovarian cancer: a meta-analysis.

Chang SJ, Hodeib M, Chang J, Bristow RE. Chang SJ, et al. Among authors: hodeib m. Gynecol Oncol. 2013 Sep;130(3):493-8. doi: 10.1016/j.ygyno.2013.05.040. Epub 2013 Jun 6. Gynecol Oncol. 2013. PMID: 23747291

8

Impact of a multivariate index assay on referral patterns for surgical management of an adnexal mass.

Bristow RE, Hodeib M, Smith A, Chan DW, Zhang Z, Fung ET, Tewari KS, Munroe DG, Ueland FR. Bristow RE, et al. Among authors: hodeib m. Am J Obstet Gynecol. 2013 Dec;209(6):581.e1-8. doi: 10.1016/j.ajog.2013.08.009. Epub 2013 Aug 11. Am J Obstet Gynecol. 2013. PMID: 23942039 Free article.

9

New paradigms in the surgical and adjuvant treatment of ovarian cancer.

Hodeib M, Eskander RN, Bristow RE. Hodeib M, et al. Minerva Ginecol. 2014 Apr;66(2):179-92. Minerva Ginecol. 2014. PMID: 24848076 Review.

10

Impact of the Coronavirus Disease 2019 pandemic on neoadjuvant chemotherapy use in patients diagnosed with epithelial type ovarian cancer.

Mukherjee A, Shammas N, Xu L, Cannavale KL, Gilfillan AD, Szamreta EA, Monberg M, Hodeib M, Chao CR. Mukherjee A, et al. Among authors: hodeib m. Front Oncol. 2024 Mar 27;14:1290719. doi: 10.3389/fonc.2024.1290719. eCollection 2024. Front Oncol. 2024. PMID: 38601762 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

30 results

Search Page

Filters